Skip to content

BEFORE Decision Aid Implementation Study

Implementation of the Begin Exploring Fertility Options, Risks and Expectations (BEFORE) Decision Aid - A Stepped Wedge Cluster Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03629509
Enrollment
224
Registered
2018-08-14
Start date
2018-09-01
Completion date
2019-12-31
Last updated
2018-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasm Female, Decision Support Techniques, Evaluation Studies, Young Adult

Keywords

decision aid, breast cancer, young females, implementation, stepped wedge trial

Brief summary

Fertility is of great importance to young women with cancer. Concerns about the ability to become pregnant after cancer treatment may influence treatment decisions and fertility decision-making is challenging. Despite these challenges, there is a lack of fertility decision support tools. Our team developed the Begin Exploring Fertility Options, Risks and Expectations (BEFORE) decision aid for young breast cancer patients in Canada. This study aims to evaluate the implementation of the BEFORE decision aid in hospital settings through a stepped wedge cluster randomized trial.

Detailed description

The investigators will conduct a stepped wedge cluster randomized trial to sequentially implement the BEFORE decision aid in clinical settings that are currently recruiting young breast cancer patients for the Reducing the bUrden of Breast cancer in Young women (RUBY) Study (www.womensresearch.ca/ruby-study/). For this trial 24 participating RUBY sites were grouped into 14 clusters (1 to 3 sites per cluster). The decision aid intervention will be sequentially rolled out over the course of 48 weeks to all clusters. None of the clusters will be switched from control to intervention during the first 6 weeks of the study to establish a baseline. Then two clusters will move from the control to the intervention every 6 weeks (called a 'step'). There will be 7 steps total during the study period. At the end of the 7th step all clusters (i.e., participating RUBY sites) will have received the decision aid intervention. The time-point of when the clusters will be switched from control to intervention will be randomized. The data collection includes obtaining secondary data collected as part of the RUBY study from all patient participants who were enrolled in RUBY during the study period. The primary outcome is the number of patients reporting that fertility tools were recommended to them, based on RUBY participant responses to a 3-month fertility questionnaire. The investigators hypothesizes that following the implementation of the decision aid intervention a 20% difference will be observed, from 10% in the control to 30% in the intervention, in the number of patients who report that someone in their care team recommended a fertility tool.

Interventions

BEHAVIORALBEFORE decision aid

Implementation of the BEFORE decision aid in clinical practice

Sponsors

Applied Health Research Centre
CollaboratorOTHER
Canadian Breast Cancer Foundation
CollaboratorOTHER
Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
Unity Health Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Stepped Wedge Cluster Randomized Trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Young females diagnosed with histologically-confirmed breast cancer will be eligible to participate if they: 1. are age =18 years and prior to their 41st birthday; 2. are able to provide verbal informed consent and complete the interviews in English or French; 3. completed the 3-month fertility questionnaire as part of the RUBY Study.

Design outcomes

Primary

MeasureTime frameDescription
Patient-reported outcome questionnaire - Fertility Preservation Questionnaire3 months from date of randomizationNumber of patients reporting that fertility tools were recommended to them following their breast cancer diagnosis

Secondary

MeasureTime frameDescription
BEFORE decision aid online survey - Provider Recommendation of Decision AidFrom date of randomization until the end of the study at 48 weeksSpecific provider who recommended the BEFORE decision aid to the patient
BEFORE decision aid online survey - Patient Learning About Decision AidFrom date of randomization until the end of the study at 48 weeksHow the patient first learned about the aid (e.g, by the poster or their care provider)
BEFORE decision aid online survey - Patient SatisfactionFrom date of randomization until the end of the study at 48 weeksPatient satisfaction with the way they found out about the BEFORE decision aid

Other

MeasureTime frameDescription
Google Analytics - Decision Aid DownloadFrom date of randomization until the end of the study at 48 weeksNumber of people who downloaded the paper BEFORE decision aid
Google Analytics - Number of VisitsFrom date of randomization until the end of the study at 48 weeksNumber of visits to the BEFORE decision aid
Google Analytics - User LocationFrom date of randomization until the end of the study at 48 weeksBEFORE decision aid user location by province in Canada
Google Analytics - Length of VisitsFrom date of randomization until the end of the study at 48 weeksLength of visits to the BEFORE decision aid
Google Analytics - Most Visited PageFrom date of randomization until the end of the study at 48 weeksMost visited page on the BEFORE decision aid
Google Analytics - Least Visited PageFrom date of randomization until the end of the study at 48 weeksLeast visited page on the BEFORE decision aid

Countries

Canada

Contacts

Primary ContactNancy N Baxter, MD, FRCSC, FACS, PhD
baxtern@smh.ca416-864-6060
Backup ContactBrittany Speller, MSc
spellerb@smh.ca416-864-6060

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026